Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
TVTX on Nasdaq
Christopher R. Cline - trading volume in the past year for Travere Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
92.1K |
$1.81M |
$19.71 |
Sep 4, 2025 |
Direct |
|
|
| Employee stock option (right to buy) |
58K |
|
|
Jan 31, 2025 |
Direct |
Common Stock |
|
| Performance-based restricted stock units |
4.92K |
|
|
May 2, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.